This chemical is primarily utilized in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) with specific stereochemistry. It serves as a key intermediate in the production of drugs targeting neurological disorders, including antidepressants and antipsychotics. The presence of the bromophenyl group allows for further functionalization, making it valuable in creating complex molecules. Additionally, its chiral center is crucial for ensuring the desired biological activity and selectivity in the final drug product. Researchers also employ it in organic synthesis to study stereoselective reactions and to develop novel therapeutic agents.